{"data":{"id":"us-tn/tenn.-code-ann.-63-2-104","jurisdiction":"us-tn","citation":"Tenn. Code Ann. § 63-2-104","heading":"Electronic medical records - Information blocking prohibited - Procedure for disclosure of test results - Exclusions","body":"(a) A healthcare professional subject to this title who is considered a business associate, as that term is defined in 45 CFR § 160.103 , shall comply with: (1) The Health Insurance Portability and Accountability Act (HIPAA) ( 42 U.S.C. § 1320d et seq.) and standards for privacy of individually identifiable health information required by 45 CFR Parts 160 and 164; and (2) Federal laws regulating information blocking, as that term is defined in 45 CFR § 171.103 . (b) Notwithstanding another law to the contrary, except as provided in subsection (c), a healthcare provider requesting a medical laboratory test for a patient shall not engage in information blocking as described in 42 U.S.C. § 300jj-52 . (c) The following reports, test results, and any other related results must not be disclosed by a designated entity, as defined under § 68-29-103 , to a patient as part of the patient's electronic health record until seventy-two (72) hours after the results are finalized, unless the healthcare provider directs the release of the results before the end of that seventy-two-hour period: (1) Pathology reports or radiology reports that have a reasonable likelihood of showing a finding of new or recurring malignancy; (2) Tests that could reveal genetic markers; (3) A positive HIV test, except that this section does not prevent the disclosure of HIV test results, including viral load and CD4 count test results, to a patient living with HIV by secure internet website or other electronic means if the patient has previously been informed about the results of a positive HIV test pursuant to the requirements of this section; or (4) Presence of antigens indicating a hepatitis infection. (d) This section does not apply to a person or entity that is licensed under this title or title 68. Added by 2024 Tenn. Acts, ch. 931,s 1, eff. 5/6/2024.\n(a) A healthcare professional subject to this title who is considered a business associate, as that term is defined in 45 CFR § 160.103 , shall comply with: (1) The Health Insurance Portability and Accountability Act (HIPAA) ( 42 U.S.C. § 1320d et seq.) and standards for privacy of individually identifiable health information required by 45 CFR Parts 160 and 164; and (2) Federal laws regulating information blocking, as that term is defined in 45 CFR § 171.103 .\n(1) The Health Insurance Portability and Accountability Act (HIPAA) ( 42 U.S.C. § 1320d et seq.) and standards for privacy of individually identifiable health information required by 45 CFR Parts 160 and 164; and\n(2) Federal laws regulating information blocking, as that term is defined in 45 CFR § 171.103 .\n(b) Notwithstanding another law to the contrary, except as provided in subsection (c), a healthcare provider requesting a medical laboratory test for a patient shall not engage in information blocking as described in 42 U.S.C. § 300jj-52 .\nble health information required by 45 CFR Parts 160 and 164; and\n(2) Federal laws regulating information blocking, as that term is defined in 45 CFR § 171.103 .\n(b) Notwithstanding another law to the contrary, except as provided in subsection (c), a healthcare provider requesting a medical laboratory test for a patient shall not engage in information blocking as described in 42 U.S.C. § 300jj-52 .\n(c) The following reports, test results, and any other related results must not be disclosed by a designated entity, as defined under § 68-29-103 , to a patient as part of the patient's electronic health record until seventy-two (72) hours after the results are finalized, unless the healthcare provider directs the release of the results before the end of that seventy-two-hour period: (1) Pathology reports or radiology reports that have a reasonable likelihood of showing a finding of new or recurring malignancy; (2) Tests that could reveal genetic markers; (3) A positive HIV test, except that this section does not prevent the disclosure of HIV test results, including viral load and CD4 count test results, to a patient living with HIV by secure internet website or other electronic means if the patient has previously been informed about the results of a positive HIV test pursuant to the requirements of this section; or (4) Presence of antigens indicating a hepatitis infection.\n(1) Pathology reports or radiology reports that have a reasonable likelihood of showing a finding of new or recurring malignancy;\n(2) Tests that could reveal genetic markers;\n(3) A positive HIV test, except that this section does not prevent the disclosure of HIV test results, including viral load and CD4 count test results, to a patient living with HIV by secure internet website or other electronic means if the patient has previously been informed about the results of a positive HIV test pursuant to the requirements of this section; or\n(4) Presence of antigens indicating a hepatitis infection.\n(d) This section does not apply to a person or entity that is licensed under this title or title 68.","path":["TN Code","Title 63","Chapter 2"],"source_url":"https://oss-data-us.vaquill.ai/v2026.08/us_tn_statutes.parquet","current_through":"2026-08-14","vintage":"open-us-law v2026.08, retrieved 2026-09-14","retrieved_at":"2026-09-14T18:32:26Z","sha256":"9dddf7009c0da95a76cc3536a7e0fe5cfdc61e01cc1f381df3818fe41fe47563","source_id":"us-tn","stale":false,"prev":"us-tn/tenn.-code-ann.-63-2-103","next":"us-tn/tenn.-code-ann.-63-30-101"},"notice":"GroundRules: Original legal text. Not legal advice."}